Identification and characterization of methylation-mediated transcriptional dysregulation dictate methylation roles in preeclampsia
Open Access
- 30 January 2020
- journal article
- research article
- Published by Springer Nature in Human Genomics
- Vol. 14 (1) , 1-10
Abstract
Preeclampsia (PE) is a heterogeneous, hypertensive disorder of pregnancy, with no robust biomarkers or effective treatments. PE increases the risk of poor outcomes for both the mother and the baby. Methylation-mediated transcriptional dysregulation motifs (methTDMs) could contribute the PE development. However, precise functional roles of methTDMs in PE have not been globally described. Here, we develop a comprehensive and computational pipeline to identify PE-specific methTDMs following TF, gene, methylation expression profile, and experimentally verified TF-gene interactions. The regulation patterns of methTDMs are multiple and complex in PE and contain relax inhibition, intensify inhibition, relax activation, intensify activation, reverse activation, and reverse inhibition. A core module is extracted from global methTDM network to further depict the mechanism of methTDMs in PE. The common and specific features of any two kinds of regulation pattern are also analyzed in PE. Some key methylation sites, TFs, and genes such as IL2RG are identified in PE. Functional analysis shows that methTDMs are associated with immune-, insulin-, and NK cell-related functions. Drug-related network identifies some key drug repurposing candidates such as NADH. Collectively, the study highlighted the effect of methylation on the transcription process in PE. MethTDMs could contribute to identify specific biomarkers and drug repurposing candidates for PE.Keywords
This publication has 42 references indexed in Scilit:
- Gene Regulation, Modulation, and Their Applications in Gene Expression Data AnalysisAdvances in Bioinformatics, 2013
- The genetics of pre-eclampsia and other hypertensive disorders of pregnancyBest Practice & Research Clinical Obstetrics & Gynaecology, 2011
- Maternal Preeclampsia and Neonatal OutcomesJournal of Pregnancy, 2011
- Maternal insulin resistance and preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2011
- STOX1: Key Player in Trophoblast Dysfunction Underlying Early Onset Preeclampsia with Growth RetardationJournal of Pregnancy, 2010
- Genome-wide identification of post-translational modulators of transcription factor activity in human B cellsNature Biotechnology, 2009
- Angiogenic factors and natural killer (NK) cells in the pathogenesis of preeclampsiaJournal of Reproductive Immunology, 2007
- Methylation adjacent to negatively regulating AP-1 site reactivates TrkA gene expression during cancer progressionOncogene, 2005
- Circulating Corticotropin-Releasing Hormone mRNA in Maternal Plasma: Relationship with Gestational Age and Severity of PreeclampsiaClinical Chemistry, 2004
- Maternal and fetal genetic factors account for most of familial aggregation of preeclampsia: A population‐based Swedish cohort studyAmerican Journal of Medical Genetics Part A, 2004